We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+18.18%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$1.12B
AUM Growth
+$507M
Cap. Flow
+$424M
Cap. Flow %
37.86%
Top 10 Hldgs %
69.37%
Holding
669
New
238
Increased
59
Reduced
66
Closed
278

Sector Composition

Rank Sector Weight
1 Financials 8.86%
2 Healthcare 4.92%
3 Technology 4.04%
4 Communication Services 3.4%
5 Industrials 2.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANIK icon
151
CALL
Anika Therapeutics
ANIK
$277M
$289K 0.03%
75,000
+18,200
+32% +$691K
UWMC icon
152
UWM Holdings
UWMC
$2.26B
$289K 0.03%
+22,000
New +$230K
YSAC
153
DELISTED
Yellowstone Acquisition Company
YSAC
$280K 0.03%
+27,680
New +$285K
PRSP
154
DELISTED
Perspecta Inc. Common Stock
PRSP
$279K 0.02%
+11,597
New +$249K
CELU icon
155
Celularity
CELU
$19.9M
$275K 0.02%
2,500
-2,355
-49% -$250K
AMC icon
156
PUT
AMC Entertainment Holdings
AMC
$2.16B
$274K 0.02%
54,420
+48,490
+818% +$1.59M
RBAC
157
DELISTED
RedBall Acquisition Corp.
RBAC
$272K 0.02%
+25,000
New +$260K
TBPH icon
158
Theravance Biopharma
TBPH
$876M
$260K 0.02%
+14,622
New +$262K
BKSY icon
159
BlackSky Technology
BKSY
$1.17B
$259K 0.02%
3,087
-2,534
-45% -$206K
CCV.U
160
DELISTED
Churchill Capital Corp V Units, each consisting of one share of Class A common stock, and one-fourth of one redeemable warrant
CCV.U
$257K 0.02%
+24,518
New +$257K
TLRY icon
161
CALL
Tilray
TLRY
$602M
$256K 0.02%
35,260
-5,900
-14% -$430K
PBR icon
162
CALL
Petrobras
PBR
$118B
$255K 0.02%
196,300
VHAQ.U
163
DELISTED
Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock
VHAQ.U
$255K 0.02%
+25,000
New +$256K
RKLB icon
164
Rocket Lab Corp
RKLB
$50B
$253K 0.02%
+25,000
New +$255K
JSPR icon
165
Jasper Therapeutics
JSPR
$26.6M
$250K 0.02%
2,500
-1,000
-29% -$99.5K
BMY.RT
166
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$242K 0.02%
+350,000
New +$746K
YOLO icon
167
AdvisorShares Pure Cannabis ETF
YOLO
$31.6M
$238K 0.02%
+13,989
New +$199K
XBI icon
168
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.4B
$236K 0.02%
49,600
+27,600
+125% +$3.54M
ASLEW
169
DELISTED
AerSale Corp Warrants
ASLEW
$235K 0.02%
+126,166
New +$85.1K
JOBY icon
170
Joby Aviation
JOBY
$8.71B
$231K 0.02%
+20,000
New +$222K
TALKW
171
DELISTED
Talkspace Inc Warrant
TALKW
$214K 0.02%
124,199
+91,211
+276% +$96.8K
HTT
172
High Templar Tech Ltd
HTT
$394M
$209K 0.02%
151,470
-777
-0.5% -$1.06K
VYGG.WS
173
DELISTED
Vy Global Growth Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
VYGG.WS
$206K 0.02%
+100,000
New +$181K
AUPH icon
174
PUT
Aurinia Pharmaceuticals
AUPH
$2.06B
$204K 0.02%
+54,400
New +$792K
FITB
175
Fifth Third Bancorp
FITB
$51.8B
$196K 0.02%
7,096
+2,780
+64% +$70.2K

Similar funds

Cowen and Company's Q4 2020 Portfolio in Review

As of Q4 2020, Cowen and Company held 669 positions worth $1.12B, up 83% from $613M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Cowen and Company deployed $424M of net new capital in Q4 2020, opening 238 new positions and adding to 59 existing holdings. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 825,000 shares worth $114M.

By sector, the portfolio is most concentrated in Financials at 8.9% of assets, up from 8.4% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was McDonald's, an estimated $10.2M trimmed.

  • Cowen and Company's largest Q4 2020 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 825,000 shares worth $114M.
  • Cowen and Company added most to Invesco QQQ Trust in Q4 2020, an estimated $68.6M increase.
  • Cowen and Company's biggest Q4 2020 reduction was McDonald's, cutting an estimated $10.2M.
  • Cowen and Company fully exited Nikola Corporation Common Stock in Q4 2020, selling an estimated $40M.
  • Cowen and Company's ten largest holdings make up 69% of its $1.12B portfolio in Q4 2020.
  • Cowen and Company opened 238 new positions and closed 278 in Q4 2020.
  • Cowen and Company's portfolio value rose 83% quarter-over-quarter to $1.12B.

Based on Cowen and Company's 13F filing for Q4 2020, filed 8 Feb 2021.